Sheldon Adelson Treated For Cancer, In ‘Dire’ Health
Sheldon Adelson with his wife, Miriam Adelson, in February 2018. Image by Getty
By Ari Feldman March 1, 2019
Billionaire casino magnate and pro-Israel mega-donor Sheldon Adelson is being treated for cancer, Bloomberg reported.
Adelson, 85, has been out of his office since late December due to side-effects from his treatment for non-Hodgkin’s lymphoma. A lawyer representing one of Adelson’s casinos referred to his health as “dire” in court Monday.
A company spokesman told Bloomberg that Adelson’s illness has not kept him from acting as the chairman and CEO of the Las Vegas Sands Corp., Adelson’s casino empire. However, Adelson missed a call to investors in January.
Adelson is worth $39 billion, according to the Bloomberg Billionaire Index. He was the largest outside spender during the 2016 elections, and has donated hundreds of millions of dollars to Jewish and Israeli causes.
Ari Feldman is a staff writer at the Forward. Contact him at [email protected] or follow him on Twitter @aefeldman
This is a moment of great uncertainty. Here’s what you can do about it.
We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.
This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.
With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.
The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.
Support our mission to tell the Jewish story fully and fairly.
